NEWSROOM

AmpliTech Reports Third Quarter 2023 Financial Results

AmpliTech Reports Third Quarter 2023 Financial Results

-Q3 Sales of $3.4 Million, $1.5 Million Gross Profit- -Multiple New LNA Products Now Available- -Conference Call Tuesday, November 14th at 4:30 PM ET- HAUPPAUGE, NY, November 14, 2023 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly,...

read more
PRISM MarketView Spotlights Significant Market Opportunities in Global Health with Launch of Emerging Public Health Index

PRISM MarketView Spotlights Significant Market Opportunities in Global Health with Launch of Emerging Public Health Index

NEW YORK, NY, November 14, 2023 - PRISM MarketView, a leader within the financial markets and news community, has debuted its PRISM Emerging Public Health Index. https://prismmarketview.com/index/public-health/ The Public Health segment highlights the most critical health crises impacting the world’s population today - including dementia, diabetes, stroke, hypertension and heart disease - as identified by the World Health Organization (WHO). The PRISM Public Health index focuses on the...

read more
Dashang Media Announces Impressive Q3 2023 Financial Performance

Dashang Media Announces Impressive Q3 2023 Financial Performance

Hangzhou, China, November 14th, 2023 – Dashang Media (Zhejiang Dashang Media Co. Ltd.) (OTC: TKVR), a leading innovator in the short video and virtual reality (VR) industry, is excited to unveil its extraordinary third-quarter financial results for 2023, showcasing the company's rapid growth and dedication to pioneering technology. In a statement, Dashang's CEO, Wei Li, expressed, "We are thrilled to share our Q3 achievements with our valued shareholders. These results reflect our team's...

read more
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results

BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results

Company to Host a Conference Call and Webcast on November 14, 2023, at 10:30 am EDT POMPANO BEACH, FLORIDA, November 13, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the quarter ended September 30, 2023. Jason Matuszewski, Chief Executive Officer of BioStem Technologies Inc. said, “2023 has been a remarkable year of growth...

read more
Ethical Web AI Launches AI Seek 4.0 with Almost Real-Time Data

Ethical Web AI Launches AI Seek 4.0 with Almost Real-Time Data

NEW YORK, November 13, 2023 - Bubblr Inc., d/b/a Ethical Web AI. (OTCQB: BBLR), a frontrunner in ethical technology determined to revolutionize the digital domain, has released Version 4.0 of its innovative Generative AI app AI Seek, to put it even further ahead in terms of capability to all other generative AI apps such as ChatGPT 4 and Claude 2. This new version of AI Seek will now include almost real-time contemporaneous data in its answers to  AI queries that need it to answer the...

read more
AmpliTech to Host Quarterly Investor Call to Review Q3 2023 Earnings on Tuesday November 14, 4:30 PM ET; Dial-in # 1-833-630-0019 or 1-412-317-1807

AmpliTech to Host Quarterly Investor Call to Review Q3 2023 Earnings on Tuesday November 14, 4:30 PM ET; Dial-in # 1-833-630-0019 or 1-412-317-1807

HAUPPAUGE, NY, November 13, 2023 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks and a worldwide distributor of packages and lids for integrated circuit assembly, and designer of complete 5G/6G systems, today announced that it will host its quarterly earnings call for Q3 2023 on Tuesday, November 14th at 4:30 p.m. ET to review the progress of its growth...

read more
Franklin Mining Bolivia’s (a branch of Franklin Mining, Inc.) Joint Venture Partner, Rockin’ G Gold Begins Gold Recovery Operation in Bolivia’s Yuyo Concession

Franklin Mining Bolivia’s (a branch of Franklin Mining, Inc.) Joint Venture Partner, Rockin’ G Gold Begins Gold Recovery Operation in Bolivia’s Yuyo Concession

Carson City, NV, November 13, 2023 – Rockin’ G Gold LLC, Franklin Mining Bolivia's (a branch of Franklin Mining, Inc.) (OTC Pink: FMNJ) Joint Venture Partner, has today announced that gold recovery is underway at Bolivia’s Yuyo Riverbed. Early daily production results this week reached 412 grams. Daily production increases are expected to rise as additional capacity is achieved. Yuyo Riverbed’s gold recovery operation is an extension of Franklin Mining’s contract with Cooperativa Minera Rio...

read more
PRISM MediaWire – Weekly Press Resume – Nov. 6 to Nov. 10, 2023

PRISM MediaWire – Weekly Press Resume – Nov. 6 to Nov. 10, 2023

New York, New York, Nov. 10, 2023 PRISM MediaWire - Weekly Press Resume Nov. 6 to Nov. 10, 2023 Two Hands Corporation Launches Sports Illustrated Line Protein Bars in Canada https://prismmediawire.com/two-hands-corporation-launches-sports-illustrated-line-protein-bars-in-canada/ BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023...

read more
Lipella Pharmaceuticals Granted FDA Orphan Designation for Oral Graft-versus-Host Disease Drug

Lipella Pharmaceuticals Granted FDA Orphan Designation for Oral Graft-versus-Host Disease Drug

“GvHD affects approximately 30,000 Americans and oral GvHD causes significant oral pain and discomfort, making it difficult for patients to eat, drink and speak. Oral GvHD is a great unmet need in cancer survivors.” Dr. Michael Chancellor, Chief Medical Officer at Lipella Pharmaceuticals Pittsburgh, PA, November 10, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our, “us” or the “Company”), has received Orphan Drug Designation for its LP-310 drug candidate for oral...

read more
Oncocyte Reports Third Quarter 2023 Financial Results

Oncocyte Reports Third Quarter 2023 Financial Results

-Launching First Products in 1H 2024- -Conference Call on Thursday, November 9, 2023, at 5:00 a.m. PT / 8:00 a.m. ET- IRVINE, CA, November 09, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today reported financial results for the third quarter of 2023, ended September 30, 2023. Third Quarter and Recent Highlights VitaGraft™ Kidney, the Company’s kidney transplant diagnostic test, received a positive coverage decision from CMS coverage; commercial revenue is...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850